Archives: : Drug Discovery

AI in Drug Discovery 2022 event (14-15 Mar, London)

on December 16, 2021

Mar 2022 - Intellegens is speaking at the AI in Drug Discovery event in London.

Alchemite™ machine learning identifies potential antimalarial drug compound

on November 17, 2021

With Optibrium and Open Source Malaria | Now published in the Journal of Medicinal Chemistry

Alchemite™ powered deep learning with “small data”

on July 22, 2021

Intellegens white paper. Strategies for applying machine learning when limited data is available.

Alchemite™ validated for global pharma data in peer-reviewed study

on June 29, 2021

Optimising kinase profiling programs with Optibrium and Genentech

on June 2, 2021

Optibrium and Genentech - drug discovery | Accurate models despite sparse data

Alchemite white paper

Alchemite white paper

Alchemite™ deep learning – solving complex problems with real-world data

on April 23, 2021

Intellegens white paper. An overview of the Alchemite™ deep learning technology.

Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform

on December 3, 2020

Predicting pharmacokinetics with Optibrium and AstraZeneca

on November 11, 2020

Optibrium and AstraZeneca - drug discovery | Successfully predicts pharmacokinetics

7 Examples of How Materials & Chemicals Companies Innovate with AI

on November 11, 2020

Launch of Cerella, a novel AI platform for active learning in drug discovery

on November 2, 2020

Machine Learning for Precision Medicine – Stem Cell Therapy

on September 21, 2020

Imputing heterogeneous drug discovery data

on June 22, 2020